Lunit obtains new CE mark for AI DBT solution
South Korean medical AI company Lunit has received a CE mark under Europe's latest Medical Device Regulation for its AI software for digital breast tomosynthesis (DBT) analysis.
Called Lunit INSIGHT DBT, the software solution analyses 3D images from DBT, enabling fast and accurate diagnosis of breast cancer.
In a press statement, Lunit disclosed its...
